Envista Holdings Corp (NYSE: NVST) Stock Competitors & Peer Comparison
See NVST's competitors and their performance on the NYSE and across the wider stock market.
Peer Comparison Table: Medical - Instruments & Supplies Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for NVST and its NYSE peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| NVST | $23.46 | +1.30% | 3.8B | 15.96 | $1.47 | N/A |
| ISRG | $391.95 | -2.32% | 138.5B | 40.74 | $9.62 | N/A |
| BDXA | $59.24 | -2.24% | 55.9B | 45.70 | $1.30 | +2.25% |
| BDX | $176.80 | -0.71% | 48.7B | 13.60 | $13.00 | +2.25% |
| RMD | $218.89 | -1.02% | 31.8B | 20.33 | $10.77 | +1.12% |
| MDLN | $35.61 | +1.92% | 30.1B | 26.09 | $1.36 | N/A |
| WST | $364.98 | -0.01% | 25.7B | 42.94 | $8.50 | +0.24% |
| HOLX | $76.01 | +0.00% | 17B | 31.54 | $2.41 | N/A |
| SOLV | $87.85 | +0.09% | 15.2B | 12.37 | $7.10 | N/A |
| BDXB | $48.16 | +1.39% | 13.7B | 7.60 | $6.33 | +2.25% |
Stock Comparison
Intuitive Surgical, Inc. (NASDAQ: ISRG)
NVST vs ISRG Comparison October 2026
Envista Holdings Corp (NYSE: NVST) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVST stands at 3.8B. In comparison, ISRG has a market cap of 138.5B. Regarding current trading prices, NVST is priced at $23.46 on the NYSE, while ISRG trades at $391.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVST currently has a P/E ratio of 15.96, whereas ISRG's P/E ratio is 40.74. In terms of profitability, NVST's ROE is +0.03%, compared to ISRG's ROE of +0.18%. Regarding short-term risk, NVST is less volatile compared to ISRG. This indicates lower risk in terms of short-term price fluctuations for NVST.Check ISRG's competition here
Becton, Dickinson and Company (NYSE: BDXA)
NVST vs BDXA Comparison October 2026
Envista Holdings Corp (NYSE: NVST) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVST stands at 3.8B. In comparison, BDXA has a market cap of 55.9B. Regarding current trading prices, NVST is priced at $23.46 on the NYSE, while BDXA trades at $59.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVST currently has a P/E ratio of 15.96, whereas BDXA's P/E ratio is 45.70. In terms of profitability, NVST's ROE is +0.03%, compared to BDXA's ROE of +0.04%. Regarding short-term risk, NVST is less volatile compared to BDXA. This indicates lower risk in terms of short-term price fluctuations for NVST.Check BDXA's competition here
Becton, Dickinson and Company (NYSE: BDX)
NVST vs BDX Comparison October 2026
Envista Holdings Corp (NYSE: NVST) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVST stands at 3.8B. In comparison, BDX has a market cap of 48.7B. Regarding current trading prices, NVST is priced at $23.46 on the NYSE, while BDX trades at $176.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVST currently has a P/E ratio of 15.96, whereas BDX's P/E ratio is 13.60. In terms of profitability, NVST's ROE is +0.03%, compared to BDX's ROE of +0.04%. Regarding short-term risk, NVST is more volatile compared to BDX. This indicates higher risk in terms of short-term price fluctuations for NVST.Check BDX's competition here
ResMed Inc. (NYSE: RMD)
NVST vs RMD Comparison October 2026
Envista Holdings Corp (NYSE: NVST) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVST stands at 3.8B. In comparison, RMD has a market cap of 31.8B. Regarding current trading prices, NVST is priced at $23.46 on the NYSE, while RMD trades at $218.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVST currently has a P/E ratio of 15.96, whereas RMD's P/E ratio is 20.33. In terms of profitability, NVST's ROE is +0.03%, compared to RMD's ROE of +0.24%. Regarding short-term risk, NVST is more volatile compared to RMD. This indicates higher risk in terms of short-term price fluctuations for NVST.Check RMD's competition here
Medline Inc. (NASDAQ: MDLN)
NVST vs MDLN Comparison October 2026
Envista Holdings Corp (NYSE: NVST) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVST stands at 3.8B. In comparison, MDLN has a market cap of 30.1B. Regarding current trading prices, NVST is priced at $23.46 on the NYSE, while MDLN trades at $35.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVST currently has a P/E ratio of 15.96, whereas MDLN's P/E ratio is 26.09. In terms of profitability, NVST's ROE is +0.03%, compared to MDLN's ROE of +0.05%. Regarding short-term risk, NVST is more volatile compared to MDLN. This indicates higher risk in terms of short-term price fluctuations for NVST.Check MDLN's competition here
West Pharmaceutical Services, Inc. (NYSE: WST)
NVST vs WST Comparison October 2026
Envista Holdings Corp (NYSE: NVST) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVST stands at 3.8B. In comparison, WST has a market cap of 25.7B. Regarding current trading prices, NVST is priced at $23.46 on the NYSE, while WST trades at $364.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVST currently has a P/E ratio of 15.96, whereas WST's P/E ratio is 42.94. In terms of profitability, NVST's ROE is +0.03%, compared to WST's ROE of +0.19%. Regarding short-term risk, NVST is more volatile compared to WST. This indicates higher risk in terms of short-term price fluctuations for NVST.Check WST's competition here
Hologic, Inc. (NASDAQ: HOLX)
NVST vs HOLX Comparison October 2026
Envista Holdings Corp (NYSE: NVST) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVST stands at 3.8B. In comparison, HOLX has a market cap of 17B. Regarding current trading prices, NVST is priced at $23.46 on the NYSE, while HOLX trades at $76.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVST currently has a P/E ratio of 15.96, whereas HOLX's P/E ratio is 31.54. In terms of profitability, NVST's ROE is +0.03%, compared to HOLX's ROE of +0.11%. Regarding short-term risk, NVST is more volatile compared to HOLX. This indicates higher risk in terms of short-term price fluctuations for NVST.Check HOLX's competition here
Solventum Corporation (NYSE: SOLV)
NVST vs SOLV Comparison October 2026
Envista Holdings Corp (NYSE: NVST) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVST stands at 3.8B. In comparison, SOLV has a market cap of 15.2B. Regarding current trading prices, NVST is priced at $23.46 on the NYSE, while SOLV trades at $87.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVST currently has a P/E ratio of 15.96, whereas SOLV's P/E ratio is 12.37. In terms of profitability, NVST's ROE is +0.03%, compared to SOLV's ROE of +0.29%. Regarding short-term risk, NVST is more volatile compared to SOLV. This indicates higher risk in terms of short-term price fluctuations for NVST.Check SOLV's competition here
Becton, Dickinson and Company (NYSE: BDXB)
NVST vs BDXB Comparison October 2026
Envista Holdings Corp (NYSE: NVST) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVST stands at 3.8B. In comparison, BDXB has a market cap of 13.7B. Regarding current trading prices, NVST is priced at $23.46 on the NYSE, while BDXB trades at $48.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVST currently has a P/E ratio of 15.96, whereas BDXB's P/E ratio is 7.60. In terms of profitability, NVST's ROE is +0.03%, compared to BDXB's ROE of +0.04%. Regarding short-term risk, NVST is more volatile compared to BDXB. This indicates higher risk in terms of short-term price fluctuations for NVST.Check BDXB's competition here
Baxter International Inc. (NYSE: BAX)
NVST vs BAX Comparison October 2026
Envista Holdings Corp (NYSE: NVST) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVST stands at 3.8B. In comparison, BAX has a market cap of 12.1B. Regarding current trading prices, NVST is priced at $23.46 on the NYSE, while BAX trades at $23.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVST currently has a P/E ratio of 15.96, whereas BAX's P/E ratio is 11.29. In terms of profitability, NVST's ROE is +0.03%, compared to BAX's ROE of -0.17%. Regarding short-term risk, NVST is more volatile compared to BAX. This indicates higher risk in terms of short-term price fluctuations for NVST.Check BAX's competition here
The Cooper Companies, Inc. (NASDAQ: COO)
NVST vs COO Comparison October 2026
Envista Holdings Corp (NYSE: NVST) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVST stands at 3.8B. In comparison, COO has a market cap of 11.1B. Regarding current trading prices, NVST is priced at $23.46 on the NYSE, while COO trades at $56.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVST currently has a P/E ratio of 15.96, whereas COO's P/E ratio is 12.48. In terms of profitability, NVST's ROE is +0.03%, compared to COO's ROE of +0.07%. Regarding short-term risk, NVST is more volatile compared to COO. This indicates higher risk in terms of short-term price fluctuations for NVST.Check COO's competition here
Avantor, Inc. (NYSE: AVTR)
NVST vs AVTR Comparison October 2026
Envista Holdings Corp (NYSE: NVST) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVST stands at 3.8B. In comparison, AVTR has a market cap of 10.4B. Regarding current trading prices, NVST is priced at $23.46 on the NYSE, while AVTR trades at $15.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVST currently has a P/E ratio of 15.96, whereas AVTR's P/E ratio is 18.04. In terms of profitability, NVST's ROE is +0.03%, compared to AVTR's ROE of -0.10%. Regarding short-term risk, NVST is less volatile compared to AVTR. This indicates lower risk in terms of short-term price fluctuations for NVST.Check AVTR's competition here
Repligen Corporation (NASDAQ: RGEN)
NVST vs RGEN Comparison October 2026
Envista Holdings Corp (NYSE: NVST) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVST stands at 3.8B. In comparison, RGEN has a market cap of 10.3B. Regarding current trading prices, NVST is priced at $23.46 on the NYSE, while RGEN trades at $181.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVST currently has a P/E ratio of 15.96, whereas RGEN's P/E ratio is 100.94. In terms of profitability, NVST's ROE is +0.03%, compared to RGEN's ROE of +0.02%. Regarding short-term risk, NVST is less volatile compared to RGEN. This indicates lower risk in terms of short-term price fluctuations for NVST.Check RGEN's competition here
AptarGroup, Inc. (NYSE: ATR)
NVST vs ATR Comparison October 2026
Envista Holdings Corp (NYSE: NVST) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVST stands at 3.8B. In comparison, ATR has a market cap of 7.7B. Regarding current trading prices, NVST is priced at $23.46 on the NYSE, while ATR trades at $119.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVST currently has a P/E ratio of 15.96, whereas ATR's P/E ratio is 20.97. In terms of profitability, NVST's ROE is +0.03%, compared to ATR's ROE of +0.14%. Regarding short-term risk, NVST is more volatile compared to ATR. This indicates higher risk in terms of short-term price fluctuations for NVST.Check ATR's competition here
Bausch + Lomb Corporation (NYSE: BLCO)
NVST vs BLCO Comparison October 2026
Envista Holdings Corp (NYSE: NVST) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVST stands at 3.8B. In comparison, BLCO has a market cap of 6.1B. Regarding current trading prices, NVST is priced at $23.46 on the NYSE, while BLCO trades at $17.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVST currently has a P/E ratio of 15.96, whereas BLCO's P/E ratio is 26.31. In terms of profitability, NVST's ROE is +0.03%, compared to BLCO's ROE of -0.03%. Regarding short-term risk, NVST is more volatile compared to BLCO. This indicates higher risk in terms of short-term price fluctuations for NVST.Check BLCO's competition here
Stevanato Group S.p.A. (NYSE: STVN)
NVST vs STVN Comparison October 2026
Envista Holdings Corp (NYSE: NVST) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVST stands at 3.8B. In comparison, STVN has a market cap of 5.5B. Regarding current trading prices, NVST is priced at $23.46 on the NYSE, while STVN trades at $20.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVST currently has a P/E ratio of 15.96, whereas STVN's P/E ratio is 30.55. In terms of profitability, NVST's ROE is +0.03%, compared to STVN's ROE of +0.09%. Regarding short-term risk, NVST is less volatile compared to STVN. This indicates lower risk in terms of short-term price fluctuations for NVST.Check STVN's competition here
Teleflex Incorporated (NYSE: TFX)
NVST vs TFX Comparison October 2026
Envista Holdings Corp (NYSE: NVST) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVST stands at 3.8B. In comparison, TFX has a market cap of 5.5B. Regarding current trading prices, NVST is priced at $23.46 on the NYSE, while TFX trades at $124.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVST currently has a P/E ratio of 15.96, whereas TFX's P/E ratio is 14.19. In terms of profitability, NVST's ROE is +0.03%, compared to TFX's ROE of -0.32%. Regarding short-term risk, NVST is more volatile compared to TFX. This indicates higher risk in terms of short-term price fluctuations for NVST.Check TFX's competition here
Merit Medical Systems, Inc. (NASDAQ: MMSI)
NVST vs MMSI Comparison October 2026
Envista Holdings Corp (NYSE: NVST) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVST stands at 3.8B. In comparison, MMSI has a market cap of 5.1B. Regarding current trading prices, NVST is priced at $23.46 on the NYSE, while MMSI trades at $85.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVST currently has a P/E ratio of 15.96, whereas MMSI's P/E ratio is 21.83. In terms of profitability, NVST's ROE is +0.03%, compared to MMSI's ROE of +0.09%. Regarding short-term risk, NVST is more volatile compared to MMSI. This indicates higher risk in terms of short-term price fluctuations for NVST.Check MMSI's competition here
ICU Medical, Inc. (NASDAQ: ICUI)
NVST vs ICUI Comparison October 2026
Envista Holdings Corp (NYSE: NVST) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVST stands at 3.8B. In comparison, ICUI has a market cap of 4B. Regarding current trading prices, NVST is priced at $23.46 on the NYSE, while ICUI trades at $159.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVST currently has a P/E ratio of 15.96, whereas ICUI's P/E ratio is 19.90. In terms of profitability, NVST's ROE is +0.03%, compared to ICUI's ROE of +0.01%. Regarding short-term risk, NVST is less volatile compared to ICUI. This indicates lower risk in terms of short-term price fluctuations for NVST.Check ICUI's competition here
Pulse Biosciences, Inc. (NASDAQ: PLSE)
NVST vs PLSE Comparison October 2026
Envista Holdings Corp (NYSE: NVST) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVST stands at 3.8B. In comparison, PLSE has a market cap of 3.3B. Regarding current trading prices, NVST is priced at $23.46 on the NYSE, while PLSE trades at $47.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVST currently has a P/E ratio of 15.96, whereas PLSE's P/E ratio is -40.59. In terms of profitability, NVST's ROE is +0.03%, compared to PLSE's ROE of -0.94%. Regarding short-term risk, NVST is less volatile compared to PLSE. This indicates lower risk in terms of short-term price fluctuations for NVST.Check PLSE's competition here
AtriCure, Inc. (NASDAQ: ATRC)
NVST vs ATRC Comparison October 2026
Envista Holdings Corp (NYSE: NVST) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVST stands at 3.8B. In comparison, ATRC has a market cap of 2.8B. Regarding current trading prices, NVST is priced at $23.46 on the NYSE, while ATRC trades at $55.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVST currently has a P/E ratio of 15.96, whereas ATRC's P/E ratio is 1712.42. In terms of profitability, NVST's ROE is +0.03%, compared to ATRC's ROE of +0.02%. Regarding short-term risk, NVST is less volatile compared to ATRC. This indicates lower risk in terms of short-term price fluctuations for NVST.Check ATRC's competition here
BioLife Solutions, Inc. (NASDAQ: BLFS)
NVST vs BLFS Comparison October 2026
Envista Holdings Corp (NYSE: NVST) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVST stands at 3.8B. In comparison, BLFS has a market cap of 1.8B. Regarding current trading prices, NVST is priced at $23.46 on the NYSE, while BLFS trades at $37.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVST currently has a P/E ratio of 15.96, whereas BLFS's P/E ratio is 36.21. In terms of profitability, NVST's ROE is +0.03%, compared to BLFS's ROE of +0.13%. Regarding short-term risk, NVST is less volatile compared to BLFS. This indicates lower risk in terms of short-term price fluctuations for NVST.Check BLFS's competition here
LeMaitre Vascular, Inc. (NASDAQ: LMAT)
NVST vs LMAT Comparison October 2026
Envista Holdings Corp (NYSE: NVST) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVST stands at 3.8B. In comparison, LMAT has a market cap of 1.8B. Regarding current trading prices, NVST is priced at $23.46 on the NYSE, while LMAT trades at $78.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVST currently has a P/E ratio of 15.96, whereas LMAT's P/E ratio is 29.03. In terms of profitability, NVST's ROE is +0.03%, compared to LMAT's ROE of +0.16%. Regarding short-term risk, NVST is less volatile compared to LMAT. This indicates lower risk in terms of short-term price fluctuations for NVST.Check LMAT's competition here
Azenta, Inc. (NASDAQ: AZTA)
NVST vs AZTA Comparison October 2026
Envista Holdings Corp (NYSE: NVST) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVST stands at 3.8B. In comparison, AZTA has a market cap of 1.8B. Regarding current trading prices, NVST is priced at $23.46 on the NYSE, while AZTA trades at $38.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVST currently has a P/E ratio of 15.96, whereas AZTA's P/E ratio is 92.26. In terms of profitability, NVST's ROE is +0.03%, compared to AZTA's ROE of -0.08%. Regarding short-term risk, NVST is less volatile compared to AZTA. This indicates lower risk in terms of short-term price fluctuations for NVST.Check AZTA's competition here
DENTSPLY SIRONA Inc. (NASDAQ: XRAY)
NVST vs XRAY Comparison October 2026
Envista Holdings Corp (NYSE: NVST) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVST stands at 3.8B. In comparison, XRAY has a market cap of 1.7B. Regarding current trading prices, NVST is priced at $23.46 on the NYSE, while XRAY trades at $8.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVST currently has a P/E ratio of 15.96, whereas XRAY's P/E ratio is 6.06. In terms of profitability, NVST's ROE is +0.03%, compared to XRAY's ROE of -0.40%. Regarding short-term risk, NVST is less volatile compared to XRAY. This indicates lower risk in terms of short-term price fluctuations for NVST.Check XRAY's competition here
Kestra Medical Technologies, Ltd. (NASDAQ: KMTS)
NVST vs KMTS Comparison October 2026
Envista Holdings Corp (NYSE: NVST) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVST stands at 3.8B. In comparison, KMTS has a market cap of 1.6B. Regarding current trading prices, NVST is priced at $23.46 on the NYSE, while KMTS trades at $27.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVST currently has a P/E ratio of 15.96, whereas KMTS's P/E ratio is -10.35. In terms of profitability, NVST's ROE is +0.03%, compared to KMTS's ROE of -0.64%. Regarding short-term risk, NVST is less volatile compared to KMTS. This indicates lower risk in terms of short-term price fluctuations for NVST.Check KMTS's competition here
STAAR Surgical Company (NASDAQ: STAA)
NVST vs STAA Comparison October 2026
Envista Holdings Corp (NYSE: NVST) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVST stands at 3.8B. In comparison, STAA has a market cap of 1.1B. Regarding current trading prices, NVST is priced at $23.46 on the NYSE, while STAA trades at $22.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVST currently has a P/E ratio of 15.96, whereas STAA's P/E ratio is 39.42. In terms of profitability, NVST's ROE is +0.03%, compared to STAA's ROE of +0.01%. Regarding short-term risk, NVST is less volatile compared to STAA. This indicates lower risk in terms of short-term price fluctuations for NVST.Check STAA's competition here
Atrion Corporation (NASDAQ: ATRI)
NVST vs ATRI Comparison October 2026
Envista Holdings Corp (NYSE: NVST) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVST stands at 3.8B. In comparison, ATRI has a market cap of 809.4M. Regarding current trading prices, NVST is priced at $23.46 on the NYSE, while ATRI trades at $459.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVST currently has a P/E ratio of 15.96, whereas ATRI's P/E ratio is 64.50. In terms of profitability, NVST's ROE is +0.03%, compared to ATRI's ROE of +0.08%. Regarding short-term risk, NVST is more volatile compared to ATRI. This indicates higher risk in terms of short-term price fluctuations for NVST.Check ATRI's competition here
AngioDynamics, Inc. (NASDAQ: ANGO)
NVST vs ANGO Comparison October 2026
Envista Holdings Corp (NYSE: NVST) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVST stands at 3.8B. In comparison, ANGO has a market cap of 624.5M. Regarding current trading prices, NVST is priced at $23.46 on the NYSE, while ANGO trades at $15.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVST currently has a P/E ratio of 15.96, whereas ANGO's P/E ratio is -38.74. In terms of profitability, NVST's ROE is +0.03%, compared to ANGO's ROE of -0.21%. Regarding short-term risk, NVST is more volatile compared to ANGO. This indicates higher risk in terms of short-term price fluctuations for NVST.Check ANGO's competition here
Embecta Corp. (NASDAQ: EMBC)
NVST vs EMBC Comparison October 2026
Envista Holdings Corp (NYSE: NVST) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVST stands at 3.8B. In comparison, EMBC has a market cap of 335.2M. Regarding current trading prices, NVST is priced at $23.46 on the NYSE, while EMBC trades at $5.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVST currently has a P/E ratio of 15.96, whereas EMBC's P/E ratio is 2.17. In terms of profitability, NVST's ROE is +0.03%, compared to EMBC's ROE of -0.14%. Regarding short-term risk, NVST is less volatile compared to EMBC. This indicates lower risk in terms of short-term price fluctuations for NVST.Check EMBC's competition here
Sanara MedTech Inc. (NASDAQ: SMTI)
NVST vs SMTI Comparison October 2026
Envista Holdings Corp (NYSE: NVST) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVST stands at 3.8B. In comparison, SMTI has a market cap of 320.4M. Regarding current trading prices, NVST is priced at $23.46 on the NYSE, while SMTI trades at $34.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVST currently has a P/E ratio of 15.96, whereas SMTI's P/E ratio is -580.83. In terms of profitability, NVST's ROE is +0.03%, compared to SMTI's ROE of -4.74%. Regarding short-term risk, NVST is more volatile compared to SMTI. This indicates higher risk in terms of short-term price fluctuations for NVST.Check SMTI's competition here
OraSure Technologies, Inc. (NASDAQ: OSUR)
NVST vs OSUR Comparison October 2026
Envista Holdings Corp (NYSE: NVST) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVST stands at 3.8B. In comparison, OSUR has a market cap of 273M. Regarding current trading prices, NVST is priced at $23.46 on the NYSE, while OSUR trades at $3.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVST currently has a P/E ratio of 15.96, whereas OSUR's P/E ratio is -5.75. In terms of profitability, NVST's ROE is +0.03%, compared to OSUR's ROE of -0.15%. Regarding short-term risk, NVST is less volatile compared to OSUR. This indicates lower risk in terms of short-term price fluctuations for NVST.Check OSUR's competition here
Anbio Biotechnology Class A Ordinary Shares (NASDAQ: NNNN)
NVST vs NNNN Comparison October 2026
Envista Holdings Corp (NYSE: NVST) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVST stands at 3.8B. In comparison, NNNN has a market cap of 243.6M. Regarding current trading prices, NVST is priced at $23.46 on the NYSE, while NNNN trades at $5.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVST currently has a P/E ratio of 15.96, whereas NNNN's P/E ratio is 37.00. In terms of profitability, NVST's ROE is +0.03%, compared to NNNN's ROE of +0.27%. Regarding short-term risk, NVST is less volatile compared to NNNN. This indicates lower risk in terms of short-term price fluctuations for NVST.Check NNNN's competition here
Utah Medical Products, Inc. (NASDAQ: UTMD)
NVST vs UTMD Comparison October 2026
Envista Holdings Corp (NYSE: NVST) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVST stands at 3.8B. In comparison, UTMD has a market cap of 236M. Regarding current trading prices, NVST is priced at $23.46 on the NYSE, while UTMD trades at $74.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVST currently has a P/E ratio of 15.96, whereas UTMD's P/E ratio is 21.93. In terms of profitability, NVST's ROE is +0.03%, compared to UTMD's ROE of +0.09%. Regarding short-term risk, NVST is more volatile compared to UTMD. This indicates higher risk in terms of short-term price fluctuations for NVST.Check UTMD's competition here
Pro-Dex, Inc. (NASDAQ: PDEX)
NVST vs PDEX Comparison October 2026
Envista Holdings Corp (NYSE: NVST) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVST stands at 3.8B. In comparison, PDEX has a market cap of 204.6M. Regarding current trading prices, NVST is priced at $23.46 on the NYSE, while PDEX trades at $64.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVST currently has a P/E ratio of 15.96, whereas PDEX's P/E ratio is 15.51. In terms of profitability, NVST's ROE is +0.03%, compared to PDEX's ROE of +0.31%. Regarding short-term risk, NVST is less volatile compared to PDEX. This indicates lower risk in terms of short-term price fluctuations for NVST.Check PDEX's competition here
KORU Medical Systems, Inc. (NASDAQ: KRMD)
NVST vs KRMD Comparison October 2026
Envista Holdings Corp (NYSE: NVST) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVST stands at 3.8B. In comparison, KRMD has a market cap of 136M. Regarding current trading prices, NVST is priced at $23.46 on the NYSE, while KRMD trades at $2.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVST currently has a P/E ratio of 15.96, whereas KRMD's P/E ratio is -74.00. In terms of profitability, NVST's ROE is +0.03%, compared to KRMD's ROE of -0.11%. Regarding short-term risk, NVST is less volatile compared to KRMD. This indicates lower risk in terms of short-term price fluctuations for NVST.Check KRMD's competition here
Stereotaxis, Inc. (AMEX: STXS)
NVST vs STXS Comparison October 2026
Envista Holdings Corp (NYSE: NVST) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVST stands at 3.8B. In comparison, STXS has a market cap of 115.6M. Regarding current trading prices, NVST is priced at $23.46 on the NYSE, while STXS trades at $1.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVST currently has a P/E ratio of 15.96, whereas STXS's P/E ratio is -6.94. In terms of profitability, NVST's ROE is +0.03%, compared to STXS's ROE of -1.33%. Regarding short-term risk, NVST is less volatile compared to STXS. This indicates lower risk in terms of short-term price fluctuations for NVST.Check STXS's competition here
Akoya Biosciences, Inc. (NASDAQ: AKYA)
NVST vs AKYA Comparison October 2026
Envista Holdings Corp (NYSE: NVST) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVST stands at 3.8B. In comparison, AKYA has a market cap of 64.4M. Regarding current trading prices, NVST is priced at $23.46 on the NYSE, while AKYA trades at $1.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVST currently has a P/E ratio of 15.96, whereas AKYA's P/E ratio is -1.34. In terms of profitability, NVST's ROE is +0.03%, compared to AKYA's ROE of -1.80%. Regarding short-term risk, NVST is more volatile compared to AKYA. This indicates higher risk in terms of short-term price fluctuations for NVST.Check AKYA's competition here
Daxor Corporation (NASDAQ: DXR)
NVST vs DXR Comparison October 2026
Envista Holdings Corp (NYSE: NVST) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVST stands at 3.8B. In comparison, DXR has a market cap of 61.9M. Regarding current trading prices, NVST is priced at $23.46 on the NYSE, while DXR trades at $10.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVST currently has a P/E ratio of 15.96, whereas DXR's P/E ratio is 8.63. In terms of profitability, NVST's ROE is +0.03%, compared to DXR's ROE of +0.13%. Regarding short-term risk, NVST is less volatile compared to DXR. This indicates lower risk in terms of short-term price fluctuations for NVST.Check DXR's competition here
SkyAI, Inc. (NASDAQ: STSS)
NVST vs STSS Comparison October 2026
Envista Holdings Corp (NYSE: NVST) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVST stands at 3.8B. In comparison, STSS has a market cap of 53.7M. Regarding current trading prices, NVST is priced at $23.46 on the NYSE, while STSS trades at $1.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVST currently has a P/E ratio of 15.96, whereas STSS's P/E ratio is -0.02. In terms of profitability, NVST's ROE is +0.03%, compared to STSS's ROE of -1.54%. Regarding short-term risk, NVST is less volatile compared to STSS. This indicates lower risk in terms of short-term price fluctuations for NVST.Check STSS's competition here
Singular Genomics Systems, Inc. (NASDAQ: OMIC)
NVST vs OMIC Comparison October 2026
Envista Holdings Corp (NYSE: NVST) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVST stands at 3.8B. In comparison, OMIC has a market cap of 50.8M. Regarding current trading prices, NVST is priced at $23.46 on the NYSE, while OMIC trades at $20.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVST currently has a P/E ratio of 15.96, whereas OMIC's P/E ratio is -0.58. In terms of profitability, NVST's ROE is +0.03%, compared to OMIC's ROE of -0.43%. Regarding short-term risk, NVST is more volatile compared to OMIC. This indicates higher risk in terms of short-term price fluctuations for NVST.Check OMIC's competition here
GlucoTrack, Inc. (NASDAQ: IGAP)
NVST vs IGAP Comparison October 2026
Envista Holdings Corp (NYSE: NVST) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVST stands at 3.8B. In comparison, IGAP has a market cap of 50.2M. Regarding current trading prices, NVST is priced at $23.46 on the NYSE, while IGAP trades at $3.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVST currently has a P/E ratio of 15.96, whereas IGAP's P/E ratio is -10.52. In terms of profitability, NVST's ROE is +0.03%, compared to IGAP's ROE of +1.80%. Regarding short-term risk, NVST is more volatile compared to IGAP. This indicates higher risk in terms of short-term price fluctuations for NVST.Check IGAP's competition here
Precision Optics Corporation, Inc. (NASDAQ: POCI)
NVST vs POCI Comparison October 2026
Envista Holdings Corp (NYSE: NVST) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVST stands at 3.8B. In comparison, POCI has a market cap of 48.8M. Regarding current trading prices, NVST is priced at $23.46 on the NYSE, while POCI trades at $4.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVST currently has a P/E ratio of 15.96, whereas POCI's P/E ratio is -9.70. In terms of profitability, NVST's ROE is +0.03%, compared to POCI's ROE of -0.24%. Regarding short-term risk, NVST is less volatile compared to POCI. This indicates lower risk in terms of short-term price fluctuations for NVST.Check POCI's competition here
Nephros, Inc. (NASDAQ: NEPH)
NVST vs NEPH Comparison October 2026
Envista Holdings Corp (NYSE: NVST) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVST stands at 3.8B. In comparison, NEPH has a market cap of 40.1M. Regarding current trading prices, NVST is priced at $23.46 on the NYSE, while NEPH trades at $3.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVST currently has a P/E ratio of 15.96, whereas NEPH's P/E ratio is 61.50. In terms of profitability, NVST's ROE is +0.03%, compared to NEPH's ROE of +0.16%. Regarding short-term risk, NVST is less volatile compared to NEPH. This indicates lower risk in terms of short-term price fluctuations for NVST.Check NEPH's competition here
Harvard Bioscience, Inc. (NASDAQ: HBIO)
NVST vs HBIO Comparison October 2026
Envista Holdings Corp (NYSE: NVST) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVST stands at 3.8B. In comparison, HBIO has a market cap of 36.7M. Regarding current trading prices, NVST is priced at $23.46 on the NYSE, while HBIO trades at $8.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVST currently has a P/E ratio of 15.96, whereas HBIO's P/E ratio is -22.58. In terms of profitability, NVST's ROE is +0.03%, compared to HBIO's ROE of -0.92%. Regarding short-term risk, NVST is less volatile compared to HBIO. This indicates lower risk in terms of short-term price fluctuations for NVST.Check HBIO's competition here
Milestone Scientific Inc. (AMEX: MLSS)
NVST vs MLSS Comparison October 2026
Envista Holdings Corp (NYSE: NVST) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVST stands at 3.8B. In comparison, MLSS has a market cap of 33.5M. Regarding current trading prices, NVST is priced at $23.46 on the NYSE, while MLSS trades at $0.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVST currently has a P/E ratio of 15.96, whereas MLSS's P/E ratio is -7.57. In terms of profitability, NVST's ROE is +0.03%, compared to MLSS's ROE of -1.49%. Regarding short-term risk, NVST is less volatile compared to MLSS. This indicates lower risk in terms of short-term price fluctuations for NVST.Check MLSS's competition here
SmileDirectClub, Inc. (NASDAQ: SDC)
NVST vs SDC Comparison October 2026
Envista Holdings Corp (NYSE: NVST) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVST stands at 3.8B. In comparison, SDC has a market cap of 29.1M. Regarding current trading prices, NVST is priced at $23.46 on the NYSE, while SDC trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVST currently has a P/E ratio of 15.96, whereas SDC's P/E ratio is -0.03. In terms of profitability, NVST's ROE is +0.03%, compared to SDC's ROE of -1.96%. Regarding short-term risk, NVST is less volatile compared to SDC. This indicates lower risk in terms of short-term price fluctuations for NVST.Check SDC's competition here
Invacare Corporation (NYSE: IVC)
NVST vs IVC Comparison October 2026
Envista Holdings Corp (NYSE: NVST) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVST stands at 3.8B. In comparison, IVC has a market cap of 24.9M. Regarding current trading prices, NVST is priced at $23.46 on the NYSE, while IVC trades at $0.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVST currently has a P/E ratio of 15.96, whereas IVC's P/E ratio is -0.79. In terms of profitability, NVST's ROE is +0.03%, compared to IVC's ROE of -0.46%. Regarding short-term risk, NVST is less volatile compared to IVC. This indicates lower risk in terms of short-term price fluctuations for NVST.Check IVC's competition here
Retractable Technologies, Inc. (AMEX: RVP)
NVST vs RVP Comparison October 2026
Envista Holdings Corp (NYSE: NVST) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVST stands at 3.8B. In comparison, RVP has a market cap of 21M. Regarding current trading prices, NVST is priced at $23.46 on the NYSE, while RVP trades at $0.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVST currently has a P/E ratio of 15.96, whereas RVP's P/E ratio is -5.83. In terms of profitability, NVST's ROE is +0.03%, compared to RVP's ROE of -0.05%. Regarding short-term risk, NVST is less volatile compared to RVP. This indicates lower risk in terms of short-term price fluctuations for NVST.Check RVP's competition here
Bionano Genomics, Inc. (NASDAQ: BNGO)
NVST vs BNGO Comparison October 2026
Envista Holdings Corp (NYSE: NVST) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVST stands at 3.8B. In comparison, BNGO has a market cap of 17.2M. Regarding current trading prices, NVST is priced at $23.46 on the NYSE, while BNGO trades at $1.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVST currently has a P/E ratio of 15.96, whereas BNGO's P/E ratio is -0.50. In terms of profitability, NVST's ROE is +0.03%, compared to BNGO's ROE of -0.79%. Regarding short-term risk, NVST is less volatile compared to BNGO. This indicates lower risk in terms of short-term price fluctuations for NVST.Check BNGO's competition here
Jin Medical International Ltd. (NASDAQ: ZJYL)
NVST vs ZJYL Comparison October 2026
Envista Holdings Corp (NYSE: NVST) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVST stands at 3.8B. In comparison, ZJYL has a market cap of 15.6M. Regarding current trading prices, NVST is priced at $23.46 on the NYSE, while ZJYL trades at $1.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVST currently has a P/E ratio of 15.96, whereas ZJYL's P/E ratio is 13.61. In terms of profitability, NVST's ROE is +0.03%, compared to ZJYL's ROE of +0.04%. Regarding short-term risk, NVST is more volatile compared to ZJYL. This indicates higher risk in terms of short-term price fluctuations for NVST.Check ZJYL's competition here
Regentis Biomaterials Ltd. (AMEX: RGNT)
NVST vs RGNT Comparison October 2026
Envista Holdings Corp (NYSE: NVST) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVST stands at 3.8B. In comparison, RGNT has a market cap of 12.7M. Regarding current trading prices, NVST is priced at $23.46 on the NYSE, while RGNT trades at $1.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVST currently has a P/E ratio of 15.96, whereas RGNT's P/E ratio is -0.07. In terms of profitability, NVST's ROE is +0.03%, compared to RGNT's ROE of N/A. Regarding short-term risk, NVST is less volatile compared to RGNT. This indicates lower risk in terms of short-term price fluctuations for NVST.Check RGNT's competition here
Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (NASDAQ: CUPR)
NVST vs CUPR Comparison October 2026
Envista Holdings Corp (NYSE: NVST) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVST stands at 3.8B. In comparison, CUPR has a market cap of 6.5M. Regarding current trading prices, NVST is priced at $23.46 on the NYSE, while CUPR trades at $2.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVST currently has a P/E ratio of 15.96, whereas CUPR's P/E ratio is -1.75. In terms of profitability, NVST's ROE is +0.03%, compared to CUPR's ROE of -15.69%. Regarding short-term risk, NVST is less volatile compared to CUPR. This indicates lower risk in terms of short-term price fluctuations for NVST.Check CUPR's competition here
Femasys Inc. (NASDAQ: FEMY)
NVST vs FEMY Comparison October 2026
Envista Holdings Corp (NYSE: NVST) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVST stands at 3.8B. In comparison, FEMY has a market cap of 6.3M. Regarding current trading prices, NVST is priced at $23.46 on the NYSE, while FEMY trades at $2.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVST currently has a P/E ratio of 15.96, whereas FEMY's P/E ratio is -0.46. In terms of profitability, NVST's ROE is +0.03%, compared to FEMY's ROE of -2.26%. Regarding short-term risk, NVST is less volatile compared to FEMY. This indicates lower risk in terms of short-term price fluctuations for NVST.Check FEMY's competition here
Lucyd, Inc (NASDAQ: LUCY)
NVST vs LUCY Comparison October 2026
Envista Holdings Corp (NYSE: NVST) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVST stands at 3.8B. In comparison, LUCY has a market cap of 5.6M. Regarding current trading prices, NVST is priced at $23.46 on the NYSE, while LUCY trades at $0.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVST currently has a P/E ratio of 15.96, whereas LUCY's P/E ratio is -0.69. In terms of profitability, NVST's ROE is +0.03%, compared to LUCY's ROE of -0.89%. Regarding short-term risk, NVST is less volatile compared to LUCY. This indicates lower risk in terms of short-term price fluctuations for NVST.Check LUCY's competition here
NanoString Technologies, Inc. (NASDAQ: NSTG)
NVST vs NSTG Comparison October 2026
Envista Holdings Corp (NYSE: NVST) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVST stands at 3.8B. In comparison, NSTG has a market cap of 5.1M. Regarding current trading prices, NVST is priced at $23.46 on the NYSE, while NSTG trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVST currently has a P/E ratio of 15.96, whereas NSTG's P/E ratio is -0.03. In terms of profitability, NVST's ROE is +0.03%, compared to NSTG's ROE of -1.43%. Regarding short-term risk, NVST is less volatile compared to NSTG. This indicates lower risk in terms of short-term price fluctuations for NVST.Check NSTG's competition here
Predictive Oncology Inc. (NASDAQ: POAI)
NVST vs POAI Comparison October 2026
Envista Holdings Corp (NYSE: NVST) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVST stands at 3.8B. In comparison, POAI has a market cap of 3.6M. Regarding current trading prices, NVST is priced at $23.46 on the NYSE, while POAI trades at $4.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVST currently has a P/E ratio of 15.96, whereas POAI's P/E ratio is -0.38. In terms of profitability, NVST's ROE is +0.03%, compared to POAI's ROE of -21.19%. Regarding short-term risk, NVST is less volatile compared to POAI. This indicates lower risk in terms of short-term price fluctuations for NVST.Check POAI's competition here
Meihua International Medical Technologies Co., Ltd. (NASDAQ: MHUA)
NVST vs MHUA Comparison October 2026
Envista Holdings Corp (NYSE: NVST) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVST stands at 3.8B. In comparison, MHUA has a market cap of 2.4M. Regarding current trading prices, NVST is priced at $23.46 on the NYSE, while MHUA trades at $7.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVST currently has a P/E ratio of 15.96, whereas MHUA's P/E ratio is 0.25. In terms of profitability, NVST's ROE is +0.03%, compared to MHUA's ROE of +0.07%. Regarding short-term risk, NVST is more volatile compared to MHUA. This indicates higher risk in terms of short-term price fluctuations for NVST.Check MHUA's competition here
G Medical Innovations Holdings Ltd (NASDAQ: GMVD)
NVST vs GMVD Comparison October 2026
Envista Holdings Corp (NYSE: NVST) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVST stands at 3.8B. In comparison, GMVD has a market cap of 1.8M. Regarding current trading prices, NVST is priced at $23.46 on the NYSE, while GMVD trades at $0.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVST currently has a P/E ratio of 15.96, whereas GMVD's P/E ratio is -0.01. In terms of profitability, NVST's ROE is +0.03%, compared to GMVD's ROE of +2.09%. Regarding short-term risk, NVST is less volatile compared to GMVD. This indicates lower risk in terms of short-term price fluctuations for NVST.Check GMVD's competition here
G Medical Innovations Holdings Ltd (NASDAQ: GMVDW)
NVST vs GMVDW Comparison October 2026
Envista Holdings Corp (NYSE: NVST) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVST stands at 3.8B. In comparison, GMVDW has a market cap of 1.8M. Regarding current trading prices, NVST is priced at $23.46 on the NYSE, while GMVDW trades at $7.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVST currently has a P/E ratio of 15.96, whereas GMVDW's P/E ratio is N/A. In terms of profitability, NVST's ROE is +0.03%, compared to GMVDW's ROE of +2.09%. Regarding short-term risk, NVST is less volatile compared to GMVDW. This indicates lower risk in terms of short-term price fluctuations for NVST.Check GMVDW's competition here
Avinger, Inc. (NASDAQ: AVGR)
NVST vs AVGR Comparison October 2026
Envista Holdings Corp (NYSE: NVST) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVST stands at 3.8B. In comparison, AVGR has a market cap of 1.5M. Regarding current trading prices, NVST is priced at $23.46 on the NYSE, while AVGR trades at $0.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVST currently has a P/E ratio of 15.96, whereas AVGR's P/E ratio is -0.05. In terms of profitability, NVST's ROE is +0.03%, compared to AVGR's ROE of +17.82%. Regarding short-term risk, NVST is less volatile compared to AVGR. This indicates lower risk in terms of short-term price fluctuations for NVST.Check AVGR's competition here
NEXGEL, Inc. (NASDAQ: NXGL)
NVST vs NXGL Comparison October 2026
Envista Holdings Corp (NYSE: NVST) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVST stands at 3.8B. In comparison, NXGL has a market cap of 1.5M. Regarding current trading prices, NVST is priced at $23.46 on the NYSE, while NXGL trades at $0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVST currently has a P/E ratio of 15.96, whereas NXGL's P/E ratio is -0.25. In terms of profitability, NVST's ROE is +0.03%, compared to NXGL's ROE of -1.33%. Regarding short-term risk, NVST is less volatile compared to NXGL. This indicates lower risk in terms of short-term price fluctuations for NVST.Check NXGL's competition here
NEXGEL, Inc. (NASDAQ: NXGLW)
NVST vs NXGLW Comparison October 2026
Envista Holdings Corp (NYSE: NVST) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVST stands at 3.8B. In comparison, NXGLW has a market cap of 1.1M. Regarding current trading prices, NVST is priced at $23.46 on the NYSE, while NXGLW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVST currently has a P/E ratio of 15.96, whereas NXGLW's P/E ratio is -0.02. In terms of profitability, NVST's ROE is +0.03%, compared to NXGLW's ROE of -1.33%. Regarding short-term risk, NVST is more volatile compared to NXGLW. This indicates higher risk in terms of short-term price fluctuations for NVST.Check NXGLW's competition here
Lucyd, Inc (NASDAQ: LUCYW)
NVST vs LUCYW Comparison October 2026
Envista Holdings Corp (NYSE: NVST) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVST stands at 3.8B. In comparison, LUCYW has a market cap of 296.1K. Regarding current trading prices, NVST is priced at $23.46 on the NYSE, while LUCYW trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVST currently has a P/E ratio of 15.96, whereas LUCYW's P/E ratio is N/A. In terms of profitability, NVST's ROE is +0.03%, compared to LUCYW's ROE of -0.89%. Regarding short-term risk, NVST is less volatile compared to LUCYW. This indicates lower risk in terms of short-term price fluctuations for NVST.Check LUCYW's competition here
Antares Pharma, Inc. (NASDAQ: ATRS)
NVST vs ATRS Comparison October 2026
Envista Holdings Corp (NYSE: NVST) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVST stands at 3.8B. In comparison, ATRS has a market cap of 0. Regarding current trading prices, NVST is priced at $23.46 on the NYSE, while ATRS trades at $5.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVST currently has a P/E ratio of 15.96, whereas ATRS's P/E ratio is 14.95. In terms of profitability, NVST's ROE is +0.03%, compared to ATRS's ROE of +0.31%. Regarding short-term risk, NVST is more volatile compared to ATRS. This indicates higher risk in terms of short-term price fluctuations for NVST.Check ATRS's competition here
Invuity, Inc. (NASDAQ: IVTY)
NVST vs IVTY Comparison October 2026
Envista Holdings Corp (NYSE: NVST) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVST stands at 3.8B. In comparison, IVTY has a market cap of 0. Regarding current trading prices, NVST is priced at $23.46 on the NYSE, while IVTY trades at $7.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVST currently has a P/E ratio of 15.96, whereas IVTY's P/E ratio is -3.80. In terms of profitability, NVST's ROE is +0.03%, compared to IVTY's ROE of -2.40%. Regarding short-term risk, NVST is more volatile compared to IVTY. This indicates higher risk in terms of short-term price fluctuations for NVST.Check IVTY's competition here
Apria, Inc. (NASDAQ: APR)
NVST vs APR Comparison October 2026
Envista Holdings Corp (NYSE: NVST) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVST stands at 3.8B. In comparison, APR has a market cap of 0. Regarding current trading prices, NVST is priced at $23.46 on the NYSE, while APR trades at $37.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVST currently has a P/E ratio of 15.96, whereas APR's P/E ratio is 22.59. In terms of profitability, NVST's ROE is +0.03%, compared to APR's ROE of +9.81%. Regarding short-term risk, NVST is more volatile compared to APR. This indicates higher risk in terms of short-term price fluctuations for NVST.Check APR's competition here
Hill-Rom Holdings, Inc. (NYSE: HRC)
NVST vs HRC Comparison October 2026
Envista Holdings Corp (NYSE: NVST) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVST stands at 3.8B. In comparison, HRC has a market cap of 0. Regarding current trading prices, NVST is priced at $23.46 on the NYSE, while HRC trades at $155.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVST currently has a P/E ratio of 15.96, whereas HRC's P/E ratio is 41.92. In terms of profitability, NVST's ROE is +0.03%, compared to HRC's ROE of +0.14%. Regarding short-term risk, NVST is more volatile compared to HRC. This indicates higher risk in terms of short-term price fluctuations for NVST.Check HRC's competition here
Analogic Corporation (NASDAQ: ALOG)
NVST vs ALOG Comparison October 2026
Envista Holdings Corp (NYSE: NVST) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVST stands at 3.8B. In comparison, ALOG has a market cap of 0. Regarding current trading prices, NVST is priced at $23.46 on the NYSE, while ALOG trades at $83.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVST currently has a P/E ratio of 15.96, whereas ALOG's P/E ratio is 40.93. In terms of profitability, NVST's ROE is +0.03%, compared to ALOG's ROE of -0.15%. Regarding short-term risk, NVST is more volatile compared to ALOG. This indicates higher risk in terms of short-term price fluctuations for NVST.Check ALOG's competition here
IntriCon Corporation (NASDAQ: IIN)
NVST vs IIN Comparison October 2026
Envista Holdings Corp (NYSE: NVST) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVST stands at 3.8B. In comparison, IIN has a market cap of 0. Regarding current trading prices, NVST is priced at $23.46 on the NYSE, while IIN trades at $24.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVST currently has a P/E ratio of 15.96, whereas IIN's P/E ratio is 226.45. In terms of profitability, NVST's ROE is +0.03%, compared to IIN's ROE of -0.00%. Regarding short-term risk, NVST is more volatile compared to IIN. This indicates higher risk in terms of short-term price fluctuations for NVST.Check IIN's competition here